KR900005973A - 사이클로스포린 안과용 조성물 - Google Patents

사이클로스포린 안과용 조성물 Download PDF

Info

Publication number
KR900005973A
KR900005973A KR1019890015328A KR890015328A KR900005973A KR 900005973 A KR900005973 A KR 900005973A KR 1019890015328 A KR1019890015328 A KR 1019890015328A KR 890015328 A KR890015328 A KR 890015328A KR 900005973 A KR900005973 A KR 900005973A
Authority
KR
South Korea
Prior art keywords
composition
present
amount
cyclosporin
component
Prior art date
Application number
KR1019890015328A
Other languages
English (en)
Korean (ko)
Inventor
에드워드 피플스 로날드
Original Assignee
예안 크라머, 한스 루돌프 하우스
산도즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 예안 크라머, 한스 루돌프 하우스, 산도즈 리미티드 filed Critical 예안 크라머, 한스 루돌프 하우스
Publication of KR900005973A publication Critical patent/KR900005973A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
KR1019890015328A 1988-10-26 1989-10-25 사이클로스포린 안과용 조성물 KR900005973A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26286688A 1988-10-26 1988-10-26
US262,866 1988-10-26

Publications (1)

Publication Number Publication Date
KR900005973A true KR900005973A (ko) 1990-05-07

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890015328A KR900005973A (ko) 1988-10-26 1989-10-25 사이클로스포린 안과용 조성물

Country Status (24)

Country Link
JP (1) JPH02164830A (de)
KR (1) KR900005973A (de)
AU (1) AU626928B2 (de)
BE (1) BE1003578A4 (de)
CA (1) CA2001502A1 (de)
CH (1) CH679210A5 (de)
DE (1) DE3935517A1 (de)
DK (1) DK531289A (de)
ES (1) ES2020032A6 (de)
FI (1) FI895064A0 (de)
FR (1) FR2638089A1 (de)
GB (1) GB2224205B (de)
GR (1) GR1000611B (de)
HU (1) HU203046B (de)
IL (1) IL92120A (de)
IT (1) IT1237824B (de)
LU (1) LU87613A1 (de)
MY (1) MY106271A (de)
NL (1) NL8902657A (de)
NO (1) NO894266L (de)
NZ (1) NZ231131A (de)
PT (1) PT92120B (de)
SE (1) SE8903583L (de)
ZA (1) ZA898140B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
ES2098739T3 (es) * 1992-05-13 1997-05-01 Sandoz Ltd Composiciones oftalmicas conteniendo una cyclosporin.
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
EP0589843B1 (de) 1992-09-25 2001-11-28 Novartis AG Cyclosporin enthaltende pharmazeutische Zusammensetzungen
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
RU2158601C2 (ru) 1994-11-03 2000-11-10 Новартис Аг Новые лекарственные формы циклоспорина для орального применения с простым составом и высокой биодоступностью и способ их получения
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
DE29824679U1 (de) 1997-01-30 2002-03-28 Novartis Ag, Basel Pharmazeutische Zusammensetzungen
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
ES2402321T3 (es) * 2007-11-05 2013-04-30 Bausch & Lomb Incorporated Materiales inmiscibles en agua como vehículos para el suministro de fármacos
WO2010141648A2 (en) * 2009-06-05 2010-12-09 Allergan, Inc. Artificial tears and therapeutic uses
EP3223794A1 (de) 2014-11-25 2017-10-04 Allergan, Inc. Stabilisierte ophthalmische omega-3-zusammensetzungen
EP4201398A1 (de) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a zur topischen behandlung von augenerkrankungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
IL92120A0 (en) 1990-07-12
CH679210A5 (de) 1992-01-15
AU4371589A (en) 1990-05-03
GB2224205A (en) 1990-05-02
NZ231131A (en) 1992-06-25
DK531289D0 (da) 1989-10-25
NO894266L (no) 1990-04-27
FI895064A0 (fi) 1989-10-25
CA2001502A1 (en) 1990-04-26
NL8902657A (nl) 1990-05-16
HU895444D0 (en) 1990-01-28
IL92120A (en) 1994-02-27
BE1003578A4 (fr) 1992-04-28
MY106271A (en) 1995-04-29
IT1237824B (it) 1993-06-18
GB8924040D0 (en) 1989-12-13
DE3935517A1 (de) 1990-05-03
PT92120A (pt) 1990-04-30
NO894266D0 (no) 1989-10-26
GR1000611B (el) 1992-08-31
HUT52394A (en) 1990-07-28
SE8903583D0 (sv) 1989-10-26
DK531289A (da) 1990-04-27
GR890100690A (en) 1990-11-29
JPH02164830A (ja) 1990-06-25
IT8948485A0 (it) 1989-10-26
AU626928B2 (en) 1992-08-13
GB2224205B (en) 1992-04-15
FR2638089A1 (fr) 1990-04-27
PT92120B (pt) 1995-06-30
SE8903583L (sv) 1990-04-27
HU203046B (en) 1991-05-28
ES2020032A6 (es) 1991-07-16
LU87613A1 (fr) 1991-05-07
ZA898140B (en) 1991-06-26

Similar Documents

Publication Publication Date Title
KR900005973A (ko) 사이클로스포린 안과용 조성물
US5639474A (en) Cyclosporin soft capsule composition
KR100368181B1 (ko) 시각조직에의국부도포를위한누선특효유제
King et al. Exudative Diabetic Retinopathy spontaneous changes and effects of a corn oil diet
DE69333769T2 (de) Verwendung einer liposomalen zusammensetzung zur herstellung eines medikamentes zur behandlung von entzündlichen zuständen
DE69315447T2 (de) Verwendung einer kombination aus viscoelastischen mitteln während der chirugie
DE69307505T2 (de) Opthalmische zusammensetzungen enthaltend ein cyclosporin
KR870006923A (ko) 고도로 플루오르화된 유기 화합물의 안정한 유제
EP0650721B1 (de) Cyclosporin enthaltende Weichkapsel
ES2094688A1 (es) Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
AU4035199A (en) Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation
AT407706B (de) Prevention und behandlung ischemischer vorfälle und hieraus resultierender perfusionsverletzungen
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
Mohan et al. Topical silver sulphadiazine--a new drug for ocular keratomycosis.
Gebhardt et al. Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine
US20110294744A1 (en) Cyclosporin emulsions
Nicosia et al. Effects of vasoactive intestinal polypeptide (VIP) in human prolactin (PRL) secreting pituitary adenomas: Stimulation of PRL release and activation of adenylate cyclase
Chignell Endogenous candida endophthalmitis
DE69109676T2 (de) Verminderung von kardiovaskulären gefässverschlüssen mit ascorbat und hemmstoffen der bindung von lipoprotein (a).
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
Blanksma Concentration of timolol in aqueous humour
KR900017599A (ko) 종양 치료용 약학 조성물
RU1814073C (ru) Способ профилактики криза отторжени кератотрансплантата
RC et al. EXUDATIVE DIABETIC RETINOPATY. SPONTANEOUS CHANGES AND EFFECTS OF A CORN OIL DIET.
Schwartz APPENDIX B BIBLIOGRAPHY OF CORTICOSTEROIDS AND THE EYE

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid